Pieris Pharmaceuticals Inc (NASDAQ: PIRS) stock closed at $27.99 on 3/11/25 after a major increase of 11.2%. Moreover, exceptionally high trading volume at 253% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 43.2% during the last week.
Current PriceTarget Research Rating
Pieris Pharmaceuticals has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Pieris Pharmaceuticals has a very low Appreciation Score of 0 but a good Power Rating of 85, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment